Register Login

PHIBRO ANIMAL HEALTH CORP (PAHC)

Director BENDHEIM JACK 🟡 adjusted position in 21.1K shares (1 derivative) of PHIBRO ANIMAL HEALTH CORP (PAHC) at $59.69 ($1.2M) Transaction Date: Apr 14, 2026 | Filing ID: 044506

Full text
Register to leave comments
  • News bot April 17, 2026, 12:26 a.m.

    🔍 BENDHEIM JACK (Director)

    Company: PHIBRO ANIMAL HEALTH CORP (PAHC)

    Report Date: 2026-04-14

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 100,000
    • Total shares sold: 121,120
    • Total shares held: 16,840

    Detailed Transactions and Holdings:

    • Sold 6,548 shares of Class A Common Stock at $59.0338 per share (Direct)
      Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,572.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 492 shares of Class A Common Stock at $59.6924 per share (Direct)
      Date: 2026-04-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,080.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
    • Sold 2,623 shares of Class A Common Stock at $56.2691 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 28,457.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
    • Sold 3,618 shares of Class A Common Stock at $57.2099 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,839.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3
    • Sold 799 shares of Class A Common Stock at $58.1126 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,040.00 | transaction_form_type: 4 | Footnotes: F1, F7, F3
    • Acquired 100,000 shares of Class A Common Stock (Direct)
      Date: 2026-04-16 | Code: C | equity_swap_involved: 0 | shares_owned_after: 124,040.00 | transaction_form_type: 4 | Footnotes: F8, F3
    • Sold 5,190 shares of Class A Common Stock at $54.5552 per share (Direct)
      Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 118,850.00 | transaction_form_type: 4 | Footnotes: F1, F9, F3
    • Sold 1,850 shares of Class A Common Stock at $54.8759 per share (Direct)
      Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 117,000.00 | transaction_form_type: 4 | Footnotes: F1, F10, F3
    • Holds 0 shares of Class A Common Stock (Direct)
      Date: 2026-04-14 | Code: H | shares_owned_after: 16,840.00 | Footnotes: F11
    • Sold 100,000 shares of Class B Common Stock (Derivative)
      Date: 2026-04-16 | Code: C | equity_swap_involved: 0 | shares_owned_after: 19,496,034.00 | transaction_form_type: 4 | Footnotes: F8, F8, F3

    Footnotes:

    • F1: The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on December 11, 2025.
    • F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10.
    • F3: The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
    • F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83.
    • F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73.
    • F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88.
    • F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22.
    • F8: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date.
    • F9: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79.
    • F10: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985.
    • F11: The reported securities are directly held by Jack Bendheim.

Search

News categories